Artificial Intelligence | April 8–10, 2019 | Boston, MA USA

Drug Therapy Redefined Through Machine Learning

Wednesday, April 24th, 2019, 8:50 am - 9:40 am


The drug development process is highly complex and has many drivers. The panel will discuss the strategic impact of AI on the entire process and the implications for healthcare overall. How will the combination of factors – research strategy, drug development, regulatory approvals, reimbursement and clinical effectiveness – be influenced by the implementation of AI. Panelists will discuss short and mid-term prospects and whether AI will ultimately lead to a restructuring of the pharma model to develop new therapies.